AngioWaveNet vs iCAC Device
AI Verdict
Choose AngioWaveNet if…
Choose AngioWaveNet if your cardiac catheterization lab requires real-time or near real-time AI-powered enhancement of fluoroscopic angiograms to improve vessel visualization during interventional procedures. This tool is ideal for optimizing existing cath lab workflows and enhancing the clarity of vascular structures, regardless of your current angiography system vendor.
View AngioWaveNet →Choose iCAC Device if…
Choose iCAC Device if your institution aims to opportunistically identify and quantify coronary artery calcium from routine, non-contrast, non-gated chest CT scans already performed for other indications. This is particularly useful for early cardiovascular disease detection and risk stratification, providing adjunctive information to radiologists and integrating seamlessly with PACS or EHR systems.
View iCAC Device →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AngioWaveNet | iCAC Device |
|---|---|---|
| Pricing | Pricing options include annual software licensing or subscription-based access, tailored to cath lab volume and hospital needs. custom packages are available. | Contact for pricing |
| Deployment | Cloud-based or on-premise/servers | Software as a Medical Device (SaMD), integrates with PACS or DICOM router. Cloud-based (via Carebricks platform). |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AngioWaveNetAngioWaveNet emphasizes a 'light footprint' with 'no cart, no hardware, no downtime' and quick configuration, indicating high ease of integration into existing Cath lab workflows. It also requires minimal training, allowing clinicians to use it immediately after installation. While iCAC Device integrates with PACS/DICOM and EHRs, AngioWaveNet's specific focus on non-disruptive procedural enhancement and rapid adoption gives it an edge in practical usability.
Clinical Value
TieBoth tools offer significant, yet distinct, clinical value. AngioWaveNet directly enhances fluoroscopic angiograms for improved vessel visualization during cardiac catheterization, aiding real-time procedural decision-making. iCAC Device provides crucial adjunctive information for early cardiovascular disease detection and risk stratification by opportunistically analyzing existing CT scans. Their different but equally impactful contributions to patient care result in a tie.
Pricing & Value
AngioWaveNetAngioWaveNet provides more transparency regarding its pricing structure, offering annual software licensing or subscription-based access tailored to cath lab volume and hospital needs, with custom packages available. This allows potential buyers to understand the cost framework. In contrast, iCAC Device's 'contact for pricing' offers no initial insight, making it harder to assess value without direct engagement, despite claims of being affordable and utilizing existing equipment.
Enterprise Readiness
AngioWaveNetAngioWaveNet explicitly states it is FDA-cleared and HIPAA compliant, detailing its adherence to secure image handling within hospital networks and extensive cybersecurity testing. It also offers flexible cloud-based or on-premise deployment options. While iCAC Device is FDA-cleared and Bunkerhill Health outlines robust security practices, its initial JSON lists HIPAA compliance and BAA status as 'contact vendor for details,' making AngioWaveNet's readiness more immediately apparent and confirmed.
Innovation
TieBoth tools demonstrate significant innovation through their AI applications. AngioWaveNet's proprietary AI-powered Spatiotemporal Enhancement Processing (STEPu2122) offers a novel approach to improving real-time angiogram visualization in a traditionally less innovated field. iCAC Device's innovation lies in its 'opportunistic screening' capability, extracting new diagnostic value for early cardiovascular risk assessment from existing, routine CT scans, representing a paradigm shift in preventative care.
Support & Docs
AngioWaveNetAngioWaveNet explicitly details its support offerings, including full onboarding support, installation assistance, staff training, and access to ongoing updates and clinical resources. It also highlights minimal training due to its intuitive design. Specific details regarding comprehensive customer support, training, or extensive documentation for the iCAC Device are not readily available through the provided information or web searches, giving AngioWaveNet a clearer advantage in this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AngioWaveNet | iCAC Device |
|---|---|---|
| Product Name | AngioWaveNet | iCAC Device |
| Company | Angiowave Imaging | Bunkerhill Health |
| Primary Function / Use Case | Enhances fluoroscopic angiograms for improved vessel visualization in cardiac catheterization laboratories. | Detects and quantifies coronary artery calcium from routine, non-contrast, non-gated chest CT scans, aiding in early cardiovascular disease detection. |
| Input Data Type | Fluoroscopic angiograms | Routine, non-contrast, non-gated chest CT scans |
| Integration | Integrates with existing Cath lab workflows; Functions as a DICOM endpoint for imaging systems. | Integrates with PACS or DICOM router; Integrates with EHRs via the Carebricks platform. |
| Key Output/Result | Improved visibility of blood vessels, vascular structures, and anatomical features in angiographic images. | Estimates presence and quantity of coronary artery calcium (CAC); Visual representation of estimated CAC segmentation; Exact and four-category quantitative estimates of CAC burden in Agatston units. |
Videos
Demos, reviews, and walkthroughs featuring AngioWaveNet and iCAC Device.